Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-05

Clinical Trial Update: Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated adding isoflavones to radiation therapy for localized prostate cancer. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isoflavones (isoflavones)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED